Sugi Predict

Sugi Predict / Compounds / SCHEMBL6746802

SCHEMBL6746802

SCHEMBL6746802

CCO[Si](C)(C)c1ccc(N(c2ccc(C)cc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NFKB1 P19838 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ ENPP3 O14638 1/20 0.35
▸ ENPP1 P22413 1/20 0.35
▸ APP P05067 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6751494 1.00 RAB9A (0.36) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6745153 1.00 RAB9A (0.36) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6751493 1.00 RAB9A (0.36) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6746704 0.95 CYP2C19 (0.39) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6749553 0.95 CYP2C19 (0.39) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6748591 0.95 CYP2C19 (0.39) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6745103 0.95 CYP2C19 (0.39) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6745055 0.95 CYP2C19 (0.39) RAB9ANPC1CYP2C19SMN1; SMN2NFKB1
SCHEMBL6749620 0.94 ALDH1A1 (0.37) RAB9ANPC1CYP2C19SMN1; SMN2HPGD
SCHEMBL6748520 0.94 TARBP2 (0.33) RAB9ANPC1SMN1; SMN2POLBENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696588-B2 OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-24 — — US disclosed
EP-0861845-B1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL CO (JP) 2003-05-28 — — EP disclosed
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2002-08-22 — — US disclosed
US-6369258-B1 SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-09 — — US disclosed
EP-0861845-A2 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same EPCAM, PIEZO1, OR10J3 RAB9A 2705/4885NPC1 4618/4885CYP2C19 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.